Clinically silent cerebral circulating microemboli are noninvasively detect
able by transcranial Doppler sonography (TCD) leading to a characteristic t
ransient increase in the frequency spectrum. These TCD signals are now Know
n as "Microembolic Signals" (MES) or "High Intensity Transient Signals" (HI
TS). Experimental studies have shown that the acoustic properties of MES ar
e determined by size and structural composition of the circulating microemb
oli. Overwhelming evidence exists that these MES possess clinical relevance
enabling the assessment of the actual thromboembolic activity on an indivi
dual basis. This allowed for obtaining new etiologic and prognostic informa
tion in various patient groups suffering from, or at risk of, ischemic stro
kes. The recent introduction of sophisticated MES detection software and th
e validation of multichannel TCD monitoring has considerably improved the m
onitoring procedure and its diagnostic confidence as well. TCD detection of
MES represents a promising novel technique to refine the prevention and th
erapy of cerebrovascular diseases on a more individual basis.